Percutaneous ablation procedures for diseases of lung, prostate, kidney, liver and bone
Ask the expert
Different types of ablation methods are considered in the report, including radiofrequency ablation, cryoablation, microwave ablation. Thermal ablation is not considered.
Only percutaneous image-guided procedures are considered in the report. Endoscopic procedures are not considered.
The following conditions are considered:
- Lung cancer
- Prostate cancer
- Kidney cancer
- Tumors of long bones
- Liver cancer
Reimbursement is analyzed only for stand-alone ablation procedures. Combination of procedures is not considered.
The analysis is limited to the procedures with at least overnight hospital stay.
The report includes essential information about reimbursement and national funding, including:
- Brief overview of reimbursement system for medical devices
- Procedure coding for technology
- Diagnosis coding
- Payment mechanism for technology
- Reimbursement tariffs for technology
- Restrictions in indications or scenarios for use of technology
- Policy considerations by payers and policy-makers about technology
Reimbursement information is provided for the following geographies:
- England (UK)
Manufacturers of devices for percutaneous ablation procedures for diseases of lung, prostate, kidney, liver and bone include:
- Angiodynamics (StarBurst Radiofrequency Ablation System, Acculis MTA System, NanoKnife)
- Arthrex (CoolCut radio frequency devices, 9700 Series Arthroscopic Probes, Electrosurgical electrode)
- B Braun (Aesculap products)
- Boston Scientific (RF3000™ Radiofrequency Ablation System, LeVeen Needle Electrodes)
- EDAP TMS S.A. (Ablatherm Maxis, Ablatherm Integrated Imaging, Focal One)
- Endocare (Cryocare System)
- Ethicon (NEUWAVE Microwave Ablation System)
- IceCure Medical (IceSense3 CS system)
- Medtronic (Cool-tip RF Ablation System, Evident MW Ablation System)
- MedWaves (AveCure system)
- RF Medical (BIG TIP, VCT Electrosurgical electrodes)
- Smith&Nephew (PROCISE Electrosurgical electrode, COBLATOR◊ II Surgery System)
- SonaCare Medical (Sonablate HIFU)
- Stryker (Radiofrequency ablation Performance Platform, MultiGen 2, Venom Radiofrequency Generators)
Table of content is not available at the moment.
The Ludwig Boltzmann Institute – Health Technology Assessment (LBI-HTA) has published results of systematic literature review of evidence in relation to efficacy and safety of radiofrequency ablation for patients with metastatic spinal lesions. In conclusion, LBI-HTA recommended radiofrequency ablation of spinal metastatic lesions for inclusion in benefit catalogue with restrictions.Read more